MedTrace Logo

Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy

NCT05361070 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-02-05

No results posted yet for this study

Summary

The NSR-GENE study is a longitudinal cohort study of approximately 300 parent-child trios from the Neonatal Seizure Registry and participating site outpatient clinics that aims to evaluate whether and how genes alter the risk of post-neonatal epilepsy among children with acute provoked neonatal seizures. The researchers aim to develop prediction rules to stratify neonates into low, medium, and high risk for post-neonatal epilepsy based on clinical, electroencephalogram (EEG), magnetic resonance imaging (MRI), and genetic risk factors.

Conditions

  • Neonatal Seizure
  • Hypoxic-Ischemic Encephalopathy
  • Stroke
  • Intracranial Hemorrhage
  • Epilepsy
  • Gene Abnormality

Sponsors & Collaborators

Principal Investigators

  • Hannah C Glass, MDCM, MAS · University of California, San Francisco

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-09
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05361070 on ClinicalTrials.gov